Analyst Ratings for Rhythm Pharmaceuticals (RYTM)
RYTM Rating Summary
RYTM Price Target Summary
- Highest: $160.00 (Citizens)
- Lowest: $105.00 (H.C. Wainwright)
- Average: $138.69
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$138.69 (+32.4%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 88%
Avg. $ Target:
$138.69 (+32.4%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/27/2026 | Deutsche Bank | David Hoang | New Coverage | Hold (N/A) |
120.00 (N/A) |
111.87 (104.74) |
-6.37% | Details |
| 7/27/2026 | JPMorgan » Updated 8/7/2026 |
Priyanka Grover | New Coverage | Overweight (N/A) |
146.00 (145.00) |
102.66 (104.74) |
2.03% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
